Peninsula biotech to cut 30 jobs as it shuts down one hepatitis B to focus on others For more information please click here to contact Tuan Nguyen By Bizjournals.com Feed (2019-07-12 16:19:27) | July 20, 2022 The company is cutting its first-generation hepatitis B virus inhibitor program but is prioritizing two other potential hep B therapies. Posted in Sacramento Business Journal